Gap19 是一种衍生自 Cx43 细胞质环九个氨基酸的肽,是选择性连接蛋白 43 半通道阻滞剂。它可以防止 C 末端与 CL 的分子内相互作用,具有保护心肌作用。
产品描述
Gap19 is a peptide that corresponds to a sequence on the cytoplasmic loop (CL) of Cx43.
体外活性
Hemichannel inhibition is due to the binding of Gap19 to the C-terminus (CT) thereby preventing intramolecular CT-CL interactions.?The peptide inhibited Cx43 hemichannel unitary currents in both HeLa cells exogenously expressing Cx43 and acutely isolated pig ventricular cardiomyocytes.?Treatment with Gap19 prevented metabolic inhibition-enhanced hemichannel openings, protected cardiomyocytes against volume overload and cell death following ischemia/reperfusion in vitro and modestly decreased the infarct size after myocardial ischemia/reperfusion in mice in vivo[2].
Cas No.
1507930-57-5
分子式
C57H100N14O15
分子量
1221.51
储存和溶解度
DMSO:Insoluble
H2O:5 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years